Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between oestradiol and puerperal psychosis.
Ahokas A, Aito M, Turiainen S. Ahokas A, et al. Acta Psychiatr Scand. 2000 Feb;101(2):167-9; discussion 169-70. doi: 10.1034/j.1600-0447.2000.96005.x. Acta Psychiatr Scand. 2000. PMID: 10706019
Effect of oestradiol on postpartum depression.
Ahokas A, Kaukoranta J, Aito M. Ahokas A, et al. Psychopharmacology (Berl). 1999 Sep 1;146(1):108-10. doi: 10.1007/s002130051095. Psychopharmacology (Berl). 1999. PMID: 10485972
Role of estradiol in puerperal psychosis.
Ahokas A, Aito M. Ahokas A, et al. Psychopharmacology (Berl). 1999 Nov;147(1):108-10. doi: 10.1007/s002130051149. Psychopharmacology (Berl). 1999. PMID: 10591876
Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J; Deramciclane Dose-Finding Study Group. Naukkarinen H, et al. Among authors: ahokas a. Eur Neuropsychopharmacol. 2005 Dec;15(6):617-23. doi: 10.1016/j.euroneuro.2005.03.002. Epub 2005 Jun 9. Eur Neuropsychopharmacol. 2005. PMID: 15949921 Clinical Trial.
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.
Stein DJ, Khoo JP, Ahokas A, Jarema M, Van Ameringen M, Vavrusova L, Hӧschl C, Bauer M, Bitter I, Mosolov SN, Olivier V, Matharan S, Picarel-Blanchot F, de Bodinat C. Stein DJ, et al. Among authors: ahokas a. Eur Neuropsychopharmacol. 2018 Aug;28(8):970-979. doi: 10.1016/j.euroneuro.2018.05.006. Epub 2018 Jul 6. Eur Neuropsychopharmacol. 2018. PMID: 30135032 Clinical Trial.
52 results